# Shree Pacetronix Ltd (SHREEPAC)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹127
Day Change: +0.04%
52W High: ₹283.15
52W Low: ₹66.1
Market Cap: ₹51 Cr

## Valuation
P/E: 19.88
P/B: 3.11
EPS: ₹6.84
Book Value: ₹43.78
Dividend Yield: 0%

## Returns
1Y Return: 81.17%

## Profitability
ROE: 7.69%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Shree Pacetronix Ltd is a Medical Instruments & Supplies company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Sub Industry: Unknown

## Business Model
Overview: Shree Pacetronix Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Instruments & Supplies. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Intimation Of BM (01St/2026-2027) Of The Com. Under Reg. 29(1) And (2) Of SEBI (LODR) Regulation 2015 To Inter-Alia, Consider And Approve The Standalone & Consolidated Audited FR For The Quarter And Financial Year Ended 31.03.2026
- Announcement: Intimation Of Receipt Of Trading Approval For 75,150 Equity Shares Of Rs.10/- Each Issued At Premium Of Rs. 71/- Bearing Distinctive Numbers From 3674551 To 3749700 Issued To Promoter On A Preferential Basis Pursuant To Conversion Of Warrants.
- BSE Filing: Board Meeting Intimation for Intimation Of BM (01St/2026-2027) Of The Com. Under Reg. 29(1) And (2) Of SEBI (LODR) Regulation 2015 To Inter-Alia, Consider And Approve The Standalone & Consolidated Audited FR For The Quarter And Financial Year Ended 31.03.2026

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-19T06:15:19.782Z
Price History Updated: 2026-05-19T06:15:20.312Z
Latest Price History Date: 2026-05-19
Technicals Updated: 2026-05-19T06:15:20.312Z
Quant Updated: 2026-05-19T06:15:20.312Z
Sentiment Updated: 2026-05-19T06:15:20.312Z
Financials Status: current
Financials Updated: 2026-05-18T14:30:01.030Z
Financials Last Attempt: 2026-05-18T14:30:01.030Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹8 Cr
Operating Profit: ₹1.4 Cr (OPM 17.5%)
Net Profit: ₹0.23 Cr
Tax: ₹0.34 Cr

## Annual P&L History
Mar 2015: Rev ₹8Cr | PAT ₹0.23Cr | OPM 17.5%
Mar 2016: Rev ₹6.89Cr | PAT ₹-0.06Cr | OPM 14.95%
Mar 2017: Rev ₹7.44Cr | PAT ₹-0.09Cr | OPM 14.38%

## Balance Sheet (Mar 2015)
Total Assets: ₹8.98 Cr
Total Liabilities: ₹8.98 Cr
Borrowings: ₹2.14 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/shreepac
Disclaimer: For research and education only. Not investment advice.